NEB
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DailyMed | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | n-ethylbuphedrone | — | — | |
| Safety | ||||
| Dose · Insufflated | ||||
| Light | 10–15 mg | — | — | |
| Common | 15–30 mg | — | — | |
| Strong | 30–45 mg | — | — | |
| Dose · Oral | ||||
| Threshold | 30 mg | — | — | |
| Light | 30–50 mg | — | — | |
| Common | 50–80 mg | — | — | |
| Strong | 80–100 mg | — | — | |
| Duration | ||||
| After-effects | 1–6 hours | — | — | |
| Pharmacology | ||||
TripSit summary
N-Ethylbuphedrone, an uncommon substituted cathinone. First appeared around 2011 but has not become popular. Effects should somewhat resemble other cathinones generally. Short-acting stimulating with more dopamine action than serotonin.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.